1-8 of 8
Jun Cui
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT111: A phase 1, first-in-human study of IB-T101, an OUTLAST™ CAR-T product for the treatment of CD70-positive clear cell renal carcinoma

Free
Bo Liu, Warren Anderson, Mathew Esquivel, Adam Pecoraro, Kate Fagan-Solis, Yuning Lei, Jun Cui, Yarong Liu, Kevin Carbajal, Maximilian Richter, Matthias Schroff
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_2): CT111.
https://doi.org/10.1158/1538-7445.AM2025-CT111
Published: 25 April 2025
View articletitled, Abstract CT111: A phase 1, first-in-human study of IB-T101, an OUTLAST™ CAR-T product for the treatment of CD70-positive clear cell renal carcinoma
Journal Articles

Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1

Available to Purchase
Di Liu, Mengqiu Li, Zhiyao Zhao, Liang Zhou, Feng Zhi, Zhiyong Guo, Jun Cui
Journal: Cancer Research
Cancer Res (2024) 84 (17): 2806–2819.
https://doi.org/10.1158/0008-5472.CAN-23-3971
Published: 04 September 2024
View articletitled, Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1
Open the PDF for Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1 in another window
Includes: Supplementary data
Journal Articles

The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response

Open Access
Lei Zhang, Yuqing Li, Lingli Zhou, Houhong Zhou, Liefu Ye, Tong Ou, Huaishan Hong, Shiwen Zheng, Ziyu Zhou, Kang Wu, Zeqin Yan, Jean Paul Thiery, Jun Cui, Song Wu
Journal: Cancer Research
Cancer Res (2023) 83 (11): 1834–1850.
https://doi.org/10.1158/0008-5472.CAN-22-2485
Published: 02 June 2023
View articletitled, The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response
Open the PDF for The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response in another window
Includes: Supplementary data
Journal Articles

Abstract 4062: The discovery and development of a CRISPR/Cas9-engineered tumor-infiltrating lymphocytes product (GT316) as a next-generation TIL therapy

Free
Yarong Liu, Jingwei Sun, Yao Sheng, Jingman Wang, Jiahui Jin, Fei Li, Lingyun Chen, Di Zhou, Yongchao Tan, Quanwei Wang, Zhao Xu, Haibao Li, Pin Wang, Jun Cui
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4062.
https://doi.org/10.1158/1538-7445.AM2023-4062
Published: 04 April 2023
View articletitled, Abstract 4062: The discovery and development of a CRISPR/Cas9-engineered tumor-infiltrating lymphocytes product (GT316) as a next-generation TIL therapy
Journal Articles

Abstract 5582: Modulation of intracellular kinase signaling to improve TIL manufacturing for adoptive cell therapy

Free
Zixiao Shi, Sheng Yao, Peipei Zhao, Fei Li, Di Zhou, Jun Cui, Jingwei Sun, Yarong Liu
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5582.
https://doi.org/10.1158/1538-7445.AM2022-5582
Published: 15 June 2022
View articletitled, Abstract 5582: Modulation of intracellular kinase signaling to improve TIL manufacturing for adoptive cell therapy
Journal Articles

Correction: Porphyromonas Gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome

Free
Xi Wang, Yiqun Jia, Liling Wen, Wenxin Mu, Xianrui Wu, Tao Liu, Xiangqi Liu, Juan Fang, Yizhao Luan, Ping Chen, Jinlong Gao, Ky-Anh Nguyen, Jun Cui, Gucheng Zeng, Ping Lan, Qianming Chen, Bin Cheng, Zhi Wang
Journal: Cancer Research
Cancer Res (2022) 82 (11): 2196.
https://doi.org/10.1158/0008-5472.CAN-22-1136
Published: 06 June 2022
View articletitled, Correction: Porphyromonas Gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome
Open the PDF for Correction: Porphyromonas Gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome in another window
Journal Articles

Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome

Available to Purchase
Xi Wang, Yiqun Jia, Liling Wen, Wenxin Mu, Xianrui Wu, Tao Liu, Xiangqi Liu, Juan Fang, Yizhao Luan, Ping Chen, Jinlong Gao, Ky-Anh Nguyen, Jun Cui, Gucheng Zeng, Ping Lan, Qianming Chen, Bin Cheng, Zhi Wang
Journal: Cancer Research
Series: Author Choice
Cancer Res (2021) 81 (10): 2745–2759.
https://doi.org/10.1158/0008-5472.CAN-20-3827
Published: 01 May 2021
View articletitled, Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome
Open the PDF for Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome in another window
Includes: Supplementary data
Journal Articles

The Deubiquitinase USP38 Promotes NHEJ Repair through Regulation of HDAC1 Activity and Regulates Cancer Cell Response to Genotoxic Insults

Available to Purchase
Yongfeng Yang, Chuanzhen Yang, Tingting Li, Shuyu Yu, Tingting Gan, Jiazhi Hu, Jun Cui, Xiaofeng Zheng
Journal: Cancer Research
Cancer Res (2020) 80 (4): 719–731.
https://doi.org/10.1158/0008-5472.CAN-19-2149
Published: 14 February 2020
View articletitled, The Deubiquitinase USP38 Promotes NHEJ Repair through Regulation of HDAC1 Activity and Regulates Cancer Cell Response to Genotoxic Insults
Open the PDF for The Deubiquitinase USP38 Promotes NHEJ Repair through Regulation of HDAC1 Activity and Regulates Cancer Cell Response to Genotoxic Insults in another window
Includes: Supplementary data